Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease-2019 (COVID-19) Prevention”

Showing 5 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Post-approval studies (Phase 4)Study completedNCT04466540
What this trial is testing

Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Hospital Alemão Oswaldo Cruz 1,372
Early research (Phase 1)Study completedNCT05872958
What this trial is testing

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

Who this might be right for
COVID-19
AstraZeneca 98
Testing effectiveness (Phase 2)Study completedNCT04627467
What this trial is testing

Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)

Who this might be right for
Covid19
Fundacion Clinica Valle del Lili 3,217

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation